JP Morgan comes away ‘bullish’ from BP Q4 results, sees positive skew to consensus revisions

by | Feb 9, 2022

Analysts at JP Morgan reiterated their ‘overweight’ stance on shares of BP hailing the outfit’s ability to deliver sector-leading total shareholder returns and positive ‘skew’ to consensus estimates for the company’s earnings going forwards.
As they put it, with its fourth quarter results, BP had shown that it knew how to walk and chew gum at the same time, they said.

Regarding the chewing, BP had managed to translate “premium” free cash flow – to the tune of a FCF yield of 13.9% for 2022 – into sector leading TSR with the analysts anticipating cash returns over 2022-24 worth approximately 30% of its market capitalisation, against EU oils on 24%.

However, that had not broken its stride, with BP also executing on profitable portfolio greening.

JP Morgan said its estimates for the oil major’s earnings before interest, taxes, depreciation and amortisation were 20% beneath the company´s price-adjusted guidance.

The reason for that was the investment bank’s more cautious assumptions on BP’s downstream.

Even so, assuming Brent oil at $78 and $70 a barrel in 2022 and 2023, respectively, they were still 15% ahead of the Bloomberg consensus.

Hence the continued “positive skew” to consensus revisions.

The analysts also bumped up their target price for BP shares from 590.0p to 600.0p.

Related articles

RBC Capital cuts Rentokil price target

RBC Capital cuts Rentokil price target

(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...

Trending stories

Join our mailing list

Subscribe to our mailing list to receive regular updates!

x